Similar articles for PMID: 23099358

Year	Number of Results
1951	1
1955	1
1956	1
1990	1
1994	1
1995	1
1996	1
1997	1
1999	3
2000	4
2001	2
2002	5
2003	2
2004	4
2005	2
2006	7
2007	7
2008	2
2009	11
2010	13
2011	7
2012	21
2013	13
2014	11
2015	7
2016	4
2017	9
2018	4
2019	3
2020	5
2021	5
2022	3
2024	0

1

Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.

Frommeyer G, Schmidt M, Clauß C, Kaese S, Stypmann J, Pott C, Eckardt L, Milberg P. Frommeyer G, et al. Eur J Heart Fail. 2012 Dec;14(12):1322-31. doi: 10.1093/eurjhf/hfs163. Epub 2012 Oct 25. Eur J Heart Fail. 2012. PMID: 23099358 Free article.

2

Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.

He Z, Sun C, Xu Y, Cheng D. He Z, et al. Biomed Pharmacother. 2016 Dec;84:1760-1767. doi: 10.1016/j.biopha.2016.10.110. Epub 2016 Nov 12. Biomed Pharmacother. 2016. PMID: 27847200

3

Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.

Milberg P, Frommeyer G, Ghezelbash S, Rajamani S, Osada N, Razvan R, Belardinelli L, Breithardt G, Eckardt L. Milberg P, et al. Europace. 2013 May;15(5):761-9. doi: 10.1093/europace/eus399. Epub 2013 Feb 1. Europace. 2013. PMID: 23376977

4

New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.

Frommeyer G, Rajamani S, Grundmann F, Stypmann J, Osada N, Breithardt G, Belardinelli L, Eckardt L, Milberg P. Frommeyer G, et al. J Card Fail. 2012 Dec;18(12):939-49. doi: 10.1016/j.cardfail.2012.10.017. J Card Fail. 2012. PMID: 23207083

5

Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.

Frommeyer G, Milberg P, Uphaus T, Kaiser D, Kaese S, Breithardt G, Eckardt L. Frommeyer G, et al. Cardiovasc Ther. 2013 Dec;31(6):e63-71. doi: 10.1111/1755-5922.12035. Cardiovasc Ther. 2013. PMID: 23647657 Free article.

6

Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.

Aidonidis I, Doulas K, Hatziefthimiou A, Tagarakis G, Simopoulos V, Rizos I, Tsilimingas N, Molyvdas PA. Aidonidis I, et al. J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):94-101. doi: 10.1177/1074248412453874. Epub 2012 Aug 7. J Cardiovasc Pharmacol Ther. 2013. PMID: 22872232

7

Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.

Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL. Kumar K, et al. J Cardiovasc Electrophysiol. 2009 Jul;20(7):796-802. doi: 10.1111/j.1540-8167.2009.01437.x. Epub 2009 Feb 27. J Cardiovasc Electrophysiol. 2009. PMID: 19298570

8

A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.

Frommeyer G, Milberg P, Witte P, Stypmann J, Koopmann M, Lücke M, Osada N, Breithardt G, Fehr M, Eckardt L. Frommeyer G, et al. Eur J Heart Fail. 2011 Oct;13(10):1060-9. doi: 10.1093/eurjhf/hfr107. Epub 2011 Aug 25. Eur J Heart Fail. 2011. PMID: 21873342 Free article.

9

Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.

Frommeyer G, Sterneberg M, Dechering DG, Kaese S, Bögeholz N, Pott C, Fehr M, Bogossian H, Milberg P, Eckardt L. Frommeyer G, et al. Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12244. Cardiovasc Ther. 2017. PMID: 28039911 Free article.

10

Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?

Frommeyer G, Sterneberg M, Dechering DG, Ellermann C, Bögeholz N, Kochhäuser S, Pott C, Fehr M, Eckardt L. Frommeyer G, et al. Int J Cardiol. 2017 Jun 1;236:237-243. doi: 10.1016/j.ijcard.2017.02.055. Epub 2017 Feb 27. Int J Cardiol. 2017. PMID: 28262346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year